Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Immunology
  4. Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice

Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice

Experimental & Molecular Medicine, 2021 · DOI: https://doi.org/10.1038/s12276-021-00605-y · Published: April 15, 2021

ImmunologyMusculoskeletal Medicine

Simple Explanation

This study investigates the causes of bone loss in old age, focusing on bone marrow stromal cells (BMSCs). They found that a signaling pathway involving 4-1BB is more active in the bone marrow of older mice. The increased 4-1BB activity reduces the ability of BMSCs to form new bone through the p38 MAPK-Dkk1 pathway. Blocking this 4-1BB pathway can prevent bone loss in older mice. This research helps us understand how age-related bone loss happens and suggests new ways to treat osteoporosis by targeting the 4-1BB signaling pathway.

Study Duration
8 weeks
Participants
10–12 male C57BL/6 mice per group
Evidence Level
Not specified

Key Findings

  • 1
    4-1BB is upregulated in BMSCs from aged mice, which leads to the attenuation of osteogenic differentiation potential via the p38 MAPK-Dkk1 pathway.
  • 2
    Trabecular bone loss in aged mice can be rescued by blocking 4-1BB signaling in vivo.
  • 3
    The accumulation of 4-1BB and 4-1BBL in bone marrow contributes to bone loss in aged mice.

Research Summary

The study investigates the role of 4-1BB signaling in age-related bone loss in mice. It finds that 4-1BB and its ligand 4-1BBL accumulate in the bone marrow of aged mice. Upregulation of 4-1BB in bone marrow stromal cells (BMSCs) attenuates their osteogenic differentiation potential through the p38 MAPK-Dkk1 pathway, contributing to bone loss. Blocking 4-1BB signaling in vivo rescues trabecular bone loss in aged mice, suggesting 4-1BB as a potential therapeutic target for senile osteoporosis.

Practical Implications

Therapeutic Target

4-1BB signaling pathway can be a therapeutic target for senile osteoporosis.

Diagnostic Biomarker

4-1BB and 4-1BBL serum levels can be potential biomarkers for early osteoporosis detection.

Understanding Bone Loss

The study contributes to the understanding of the pathogenesis of age-related bone loss.

Study Limitations

  • 1
    The study is limited to mice models, and the results may not directly translate to humans.
  • 2
    The precise mechanisms underlying the upregulation of 4-1BB and 4-1BBL in aged bone marrow require further investigation.
  • 3
    The study mainly focuses on trabecular bone loss, and the effects on cortical bone are less pronounced.

Your Feedback

Was this summary helpful?

Back to Immunology